Skip to main content

Cetuximab for Head and Neck Cancer User Reviews

Brand names: Erbitux

Cetuximab has an average rating of 5.7 out of 10 from a total of 3 reviews for the treatment of Head and Neck Cancer. 33% of reviewers reported a positive experience, while 33% reported a negative experience.

Cetuximab rating summary

5.7/10 average rating

3 ratings from 3 user reviews.

Compare all 13 medications used in the treatment of Head and Neck Cancer.

10
0%
9
33%
8
0%
7
33%
6
0%
5
0%
4
0%
3
0%
2
0%
1
33%
  • Anonymous
  • November 23, 2008

Erbitux (cetuximab) "My father-in-law was diagnosed with metastic squamous cell head and neck cancer. Had 6 weeks radiation but cancer had spread. Conventional chemo did nothing. Had large tumors, one breaking through the chest wall. Could not do daily tasks. He started on Erbitux infusions and within four weeks two of the tumors had disappeared and the larger ones had shrunk. Didn't need pain medicines any more. Side effects he experienced: blood infections from the PICC line, electrolyte imbalance, rash on his body. He is happy with drug. He has lived several months longer then anticipated but he must stay on Erbitux or the cancer will come back."

7 / 10
Was this helpful?YesNo
44 Report
  • ELM
  • October 16, 2015

Erbitux (cetuximab) "I heard good things about this drug for metastatic head and neck cancer (mine began in my tongue and has moved around my mouth and into my neck - I'm a 30 year female with no risk factors), but had a severe allergic reaction during my first infusion. I felt a hot flash move from my midsection to my head, then everything started swelling, until finally my throat began to close. It was instantaneous. I only had about 10-20 cc's. Luckily, my nurse was prepared and flushed the line immediately and gave me meds to stop the reaction. My doctor has already ordered panitumumab to replace it, "

1 / 10
Was this helpful?YesNo
4 Report
  • Gob...
  • May 11, 2020

"Have been on cetuximab weekly for 15 months for head and neck (hnc), I.e. secondary tumour in pharagyal space. Tumour has shrunk and now stable with no metastasis elsewhere. Side effects of rash, nail infections, flaky skin, fatigue are bearable. My original mouth cancer surgery and radiotherapy has left me debilitated with no taste or smell, poor swallow and hence limited to a soft diet. Also my speech is poor. Quality of life has deteriorated. However cetuximab has kept me going and seems to have given me an extension of time."

9 / 10
Was this helpful?YesNo
2 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.

Learn more about Head and Neck Cancer

Symptoms and treatments